Cancer Immunotherapy How It Works and Who It’s For
The immune system exists to defend the body, yet cancer cells can sometimes slip past its defences and multiply without restraint. Because tumours originate from the body's own tissue, they can acquire ways to conceal themselves, escape immune surveillance, or actively dampen immune activity in the surrounding environment.
Immunotherapy is one approach that works to overcome this obstacle. It is a cancer treatment that strengthens the body's immune system's capacity to recognise and act against cancer cells.
📞 1800-5323-265 🌐 www.mangocancercare.com
How Does Immunotherapy Work?
The immune system relies on natural regulatory mechanisms known as "checkpoints", which are proteins that moderate immune activity and help prevent immune cells from attacking healthy tissue excessively. Certain cancer cells exploit these checkpoints, transmitting signals that cause immune cells to disregard them as a threat. Checkpoint inhibitors are a class of drugs designed to block signals such as PD-1, PD-L1, or CTLA-4, thereby restoring the immune system's capacity to recognise and target cancer cells.Beyond Checkpoint Inhibitors
Other immunotherapy approaches work in different ways, including:- Monoclonal Antibodies These are laboratory-produced proteins designed to bind to specific targets involved in cancer growth or immune responses.
- CAR-T Cell Therapy This approach modifies a patient's T cells so they can better recognise and attack certain cancer cells.
- Cancer Vaccines These are designed to stimulate the immune system to recognise and respond to specific cancer-related targets.
- Cytokine Therapies These use immune-signalling proteins to help stimulate or regulate immune responses against cancer.
Who May Be Considered for Immunotherapy?
Immunotherapy is not appropriate for every patient or every form of cancer. Oncologists typically evaluate several factors before recommending this treatment, including:- The Type and Stage of Cancer The type of cancer and how advanced it is can influence whether immunotherapy may be considered.
- Previous Treatments Received A patient's previous cancer treatments and their response to those treatments may form part of the treatment assessment.
- Overall Health The patient's general health and ability to tolerate treatment are important considerations.
- Organ Function The function of organs such as the liver, kidneys and lungs may be assessed before treatment.
- Biomarker Testing Results from relevant biomarker tests can provide information that may help guide treatment decisions.
Why Do Responses Differ?
Two patients with an identical diagnosis may respond quite differently to the same immunotherapy regimen. This variation arises because tumours differ considerably in their underlying biology, including the specific mutations present, their degree of visibility to the immune system, and the extent of pre-existing immune activity within and around the tumour microenvironment. Prior treatment history and a patient's broader immune status may also influence outcomes. Consequently, treatment decisions must always be determined by the treating oncologist, who can evaluate the complete clinical context rather than biomarker results in isolation.Understanding the Side Effects
Immunotherapy functions by amplifying immune activity. In some instances, this may cause the immune system to mistakenly target healthy tissue, a phenomenon referred to clinically as immune-related adverse events (irAEs). These events may affect the skin, gastrointestinal tract, lungs, liver, endocrine glands, or other organ systems, with severity ranging from mild to serious. Unlike some conventional chemotherapy-related side effects, immune-related effects can manifest weeks or even months after treatment initiation. Patients are therefore advised to report any new or unusual symptoms to their healthcare team without delay.How Mango Care Foundation Supports Patients
At Mango Care Foundation, we assist patients and families in understanding the support structures available around these advanced therapies, including program guidance and, wherever applicable, financial-support pathways. Where immunotherapy or another advanced treatment has been recommended, patients are encouraged to consult their healthcare team regarding the clinical aspects of care, and to engage with Mango Care Foundation for support throughout the broader treatment journey.Making Informed Treatment Decisions
If immunotherapy has been recommended, consult your oncologist to determine whether it may be relevant to your treatment plan. Your healthcare team can assess your cancer type, treatment history, biomarker results, overall health and other clinical factors before making treatment decisions. You can also contact Mango Care Foundation to learn more about available support programs and assistance throughout the treatment journey. For any information, connect with our team:📞 1800-5323-265 🌐 www.mangocancercare.com
